Search

everythinglearnresearchcommunity

for

Search:↓

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Gender identity can be more diverse than just male or female.

People with early graying hair often have lower levels of iron, ferritin, and calcium.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Premature hair graying in young men is linked to family history, obesity, and smoking.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

The Men's Training Cup Keep Training masturbation aid may help delay ejaculation and improve erectile function.

PRP can reduce pain and improve function, but more standardized research is needed.

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.

Men with genetic hair loss are more likely to have abnormal blood lipid levels, especially if the hair loss is severe.

Certain gene variations and different levels of BDNF and CRH hormones are linked to vitiligo.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

Stromal Vascular Fraction might help with male sexual dysfunction, but more research is needed to confirm its safety and effectiveness.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Some dermatology patients in Turkey use traditional medicine, with herbal remedies being most common, but these treatments can have mixed results and risks.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.